Freedom Broker changed its rating for Amgen to Hold and increased its price target to $470.

Nov 6, 2026, 8:24 PM ETOpinionRead the original at tradingview.com

Neutral

Freedom Broker became less positive on Amgen but raised its share target. These signals point in different directions, and the story reports no change to Amgen's business.

AMGN · Amgen Inc.

AI read · Neutral

The AI's read

The lower rating shows less confidence from this broker. Its higher target points the other way and suggests some room for the shares to rise. The story gives no new information about Amgen's sales, products, or results, so these mixed broker signals do not show a clear change for the company.

Get alerts for AMGN

Follow Amgen Inc. (AMGN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for AMGN

Free on the App Store and Google Play, or on the web.